TAF6L is a SAGA complex component that functions as a transcriptional coactivator with critical roles in stem cell maintenance and drug response regulation. As part of the PCAF/SAGA complex, TAF6L enables efficient histone acetylation in nucleosomal contexts, functioning as the human ortholog of yeast TAF6 1. TAF6L works with TAF5L as an epigenetic regulator essential for embryonic stem cell self-renewal, primarily through H3K9ac deposition and MYC recruitment that activates the MYC regulatory network controlling pluripotency gene expression programs 2. Structurally, TAF6L possesses a HEAT repeat domain that provides a critical docking surface for the splicing-factor module in metazoan SAGA, distinguishing human SAGA from its yeast counterpart 3. Beyond stem cell biology, TAF6L regulates cell recovery from cisplatin-induced cytotoxicity in gastric cancer cells 4 and is implicated as a potential biomarker in glioblastoma tumorigenesis through Wnt/β-catenin signaling pathways 5. Additionally, TAF6L promoters contain regulatory motifs associated with cell cycle and protein synthesis gene expression 6. These findings establish TAF6L as a multifunctional epigenetic regulator bridging developmental pluripotency networks and cancer biology.